Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $658.8700 (-0.97%) ($658.8700 - $673.1400) on Wed. Jun. 1, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 70 | Latest Price | $658.8700(-0.97%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -0.8% a day on average for past five trading days. | Weekly Trend | REGN advances 2.6% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Growth stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(57%) DIA(39%) IWD(37%) SPLV(36%) SPY(35%) | Factors Impacting REGN price | REGN will decline at least -0.86% in a week (0% probabilities). VIXM(-13%) TBT(-12%) UUP(-7%) VXX(-2%) USO(1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | -0.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $678.19(-2.85%) | 10 Day Moving Average | $673.89(-2.23%) | 20 Day Moving Average | $655.47(0.52%) | To recent high | -10.8% | To recent low | 9.8% | Market Cap | $69.859b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |